Lung cancer transcriptomes refined with laser capture microdissection

Juan Lin, Gabrielle Marquardt, Nandita Mullapudi, Tao Wang, Weiguo Han, Miao Shi, Steven Keller, Changcheng Zhu, Joseph Locker, Simon D. Spivack

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We evaluated the importance of tumor cell selection for generating gene signatures in non-small cell lung cancer. Tumor and nontumor tissue from macroscopically dissected (Macro) surgical specimens (31 pairs from 32 subjects) was homogenized, extracted, amplified, and hybridized to microarrays. Adjacent scout sections were histologically mapped; sets of approximately 1000 tumor cells and nontumor cells (alveolar or bronchial) were procured by laser capture microdissection (LCM). Within histological strata, LCM and Macro specimens exhibited approximately 67% to 80% nonoverlap in differentially expressed (DE) genes. In a representative subset, LCM uniquely identified 300 DE genes in tumor versus nontumor specimens, largely attributable to cell selection; 382 DE genes were common to Macro, Macro with preamplification, and LCM platforms. RT-qPCR validation in a 33-gene subset was confirmatory (ρ = 0.789 to 0.964, P = 0.0013 to 0.0028). Pathway analysis of LCM data suggested alterations in known cancer pathways (cell growth, death, movement, cycle, and signaling components), among others (eg, immune, inflammatory). A unique nine-gene LCM signature had higher tumor-nontumor discriminatory accuracy (100%) than the corresponding Macro signature (87%). Comparison with Cancer Genome Atlas data sets (based on homogenized Macro tissue) revealed both substantial overlap and important differences from LCM specimen results. Thus, cell selection via LCM enhances expression profiling precision, and confirms both known and under-appreciated lung cancer genes and pathways.

Original languageEnglish (US)
Pages (from-to)2868-2884
Number of pages17
JournalAmerican Journal of Pathology
Volume184
Issue number11
DOIs
StatePublished - Nov 1 2014

Fingerprint

Laser Capture Microdissection
Transcriptome
Lung Neoplasms
Neoplasms
Genes
Alveolar Epithelial Cells
Atlases
Neoplasm Genes
Non-Small Cell Lung Carcinoma
Cell Death
Genome

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Lung cancer transcriptomes refined with laser capture microdissection. / Lin, Juan; Marquardt, Gabrielle; Mullapudi, Nandita; Wang, Tao; Han, Weiguo; Shi, Miao; Keller, Steven; Zhu, Changcheng; Locker, Joseph; Spivack, Simon D.

In: American Journal of Pathology, Vol. 184, No. 11, 01.11.2014, p. 2868-2884.

Research output: Contribution to journalArticle

Lin, Juan ; Marquardt, Gabrielle ; Mullapudi, Nandita ; Wang, Tao ; Han, Weiguo ; Shi, Miao ; Keller, Steven ; Zhu, Changcheng ; Locker, Joseph ; Spivack, Simon D. / Lung cancer transcriptomes refined with laser capture microdissection. In: American Journal of Pathology. 2014 ; Vol. 184, No. 11. pp. 2868-2884.
@article{d7df6f36b4c14b688060a6ef8efe8e79,
title = "Lung cancer transcriptomes refined with laser capture microdissection",
abstract = "We evaluated the importance of tumor cell selection for generating gene signatures in non-small cell lung cancer. Tumor and nontumor tissue from macroscopically dissected (Macro) surgical specimens (31 pairs from 32 subjects) was homogenized, extracted, amplified, and hybridized to microarrays. Adjacent scout sections were histologically mapped; sets of approximately 1000 tumor cells and nontumor cells (alveolar or bronchial) were procured by laser capture microdissection (LCM). Within histological strata, LCM and Macro specimens exhibited approximately 67{\%} to 80{\%} nonoverlap in differentially expressed (DE) genes. In a representative subset, LCM uniquely identified 300 DE genes in tumor versus nontumor specimens, largely attributable to cell selection; 382 DE genes were common to Macro, Macro with preamplification, and LCM platforms. RT-qPCR validation in a 33-gene subset was confirmatory (ρ = 0.789 to 0.964, P = 0.0013 to 0.0028). Pathway analysis of LCM data suggested alterations in known cancer pathways (cell growth, death, movement, cycle, and signaling components), among others (eg, immune, inflammatory). A unique nine-gene LCM signature had higher tumor-nontumor discriminatory accuracy (100{\%}) than the corresponding Macro signature (87{\%}). Comparison with Cancer Genome Atlas data sets (based on homogenized Macro tissue) revealed both substantial overlap and important differences from LCM specimen results. Thus, cell selection via LCM enhances expression profiling precision, and confirms both known and under-appreciated lung cancer genes and pathways.",
author = "Juan Lin and Gabrielle Marquardt and Nandita Mullapudi and Tao Wang and Weiguo Han and Miao Shi and Steven Keller and Changcheng Zhu and Joseph Locker and Spivack, {Simon D.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.ajpath.2014.06.028",
language = "English (US)",
volume = "184",
pages = "2868--2884",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Lung cancer transcriptomes refined with laser capture microdissection

AU - Lin, Juan

AU - Marquardt, Gabrielle

AU - Mullapudi, Nandita

AU - Wang, Tao

AU - Han, Weiguo

AU - Shi, Miao

AU - Keller, Steven

AU - Zhu, Changcheng

AU - Locker, Joseph

AU - Spivack, Simon D.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - We evaluated the importance of tumor cell selection for generating gene signatures in non-small cell lung cancer. Tumor and nontumor tissue from macroscopically dissected (Macro) surgical specimens (31 pairs from 32 subjects) was homogenized, extracted, amplified, and hybridized to microarrays. Adjacent scout sections were histologically mapped; sets of approximately 1000 tumor cells and nontumor cells (alveolar or bronchial) were procured by laser capture microdissection (LCM). Within histological strata, LCM and Macro specimens exhibited approximately 67% to 80% nonoverlap in differentially expressed (DE) genes. In a representative subset, LCM uniquely identified 300 DE genes in tumor versus nontumor specimens, largely attributable to cell selection; 382 DE genes were common to Macro, Macro with preamplification, and LCM platforms. RT-qPCR validation in a 33-gene subset was confirmatory (ρ = 0.789 to 0.964, P = 0.0013 to 0.0028). Pathway analysis of LCM data suggested alterations in known cancer pathways (cell growth, death, movement, cycle, and signaling components), among others (eg, immune, inflammatory). A unique nine-gene LCM signature had higher tumor-nontumor discriminatory accuracy (100%) than the corresponding Macro signature (87%). Comparison with Cancer Genome Atlas data sets (based on homogenized Macro tissue) revealed both substantial overlap and important differences from LCM specimen results. Thus, cell selection via LCM enhances expression profiling precision, and confirms both known and under-appreciated lung cancer genes and pathways.

AB - We evaluated the importance of tumor cell selection for generating gene signatures in non-small cell lung cancer. Tumor and nontumor tissue from macroscopically dissected (Macro) surgical specimens (31 pairs from 32 subjects) was homogenized, extracted, amplified, and hybridized to microarrays. Adjacent scout sections were histologically mapped; sets of approximately 1000 tumor cells and nontumor cells (alveolar or bronchial) were procured by laser capture microdissection (LCM). Within histological strata, LCM and Macro specimens exhibited approximately 67% to 80% nonoverlap in differentially expressed (DE) genes. In a representative subset, LCM uniquely identified 300 DE genes in tumor versus nontumor specimens, largely attributable to cell selection; 382 DE genes were common to Macro, Macro with preamplification, and LCM platforms. RT-qPCR validation in a 33-gene subset was confirmatory (ρ = 0.789 to 0.964, P = 0.0013 to 0.0028). Pathway analysis of LCM data suggested alterations in known cancer pathways (cell growth, death, movement, cycle, and signaling components), among others (eg, immune, inflammatory). A unique nine-gene LCM signature had higher tumor-nontumor discriminatory accuracy (100%) than the corresponding Macro signature (87%). Comparison with Cancer Genome Atlas data sets (based on homogenized Macro tissue) revealed both substantial overlap and important differences from LCM specimen results. Thus, cell selection via LCM enhances expression profiling precision, and confirms both known and under-appreciated lung cancer genes and pathways.

UR - http://www.scopus.com/inward/record.url?scp=84908179099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908179099&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2014.06.028

DO - 10.1016/j.ajpath.2014.06.028

M3 - Article

C2 - 25128906

AN - SCOPUS:84908179099

VL - 184

SP - 2868

EP - 2884

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 11

ER -